Company / Return on Equity (ROE)
SI-BONE, Inc. Return on Equity (ROE) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-10.7%
FY2025
5-year range
-62.3% / -10.7%
FY2021-FY2025
Trend
+42.5%
vs FY2024
Sector context
#107 of 147
Health Care
What the data says
SI-BONE, Inc. reports negative total equity of -10.7% in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-10.7% in FY2025 with a 5-year CAGR of +15.2%.
Improved from -25.6% to -10.7% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- +51.7pp
- 5-Year Change
- +15.2pp
- 10-Year Change
- -
Sector benchmark
#107 of 147 in Health CareTop 73% of 147This company -10.7% Sector average -3.1%
▼
-241.3% below sector average
Key checks
Key Insights
- SI-BONE, Inc.'s return on equity (roe) has grown for 3 consecutive years.
- In FY2025, return on equity (roe) increased 42.5% year-over-year.
- Currently 7.5pp below the Health Care sector average.
- Lowest return on equity (roe) in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.75 (distress zone, below 1.8 threshold)
- Negative profit margin: -18.5%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -10.7% | +42.5% |
| FY2024 | -18.5% | +27.7% |
| FY2023 | -25.6% | +58.9% |
| FY2022 | -62.3% | -48.0% |
| FY2021 | -42.1% | -63.1% |
| FY2020 | -25.8% | +57.7% |
| FY2019 | -61.0% | -215.0% |
| FY2018 | -19.4% | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026